Procter & Gamble Health Ltd - 500126 - Closure of Trading Window
We would like to inform you that the Trading Window of the Company shall remain closed from July 1, 2024 until 48 hours from the publication of the audited financial results for the financial year ended June 30, 2024, as further detailed in enclosed letter. Procter & Gamble Health Ltd - 500126 - Board Meeting Intimation for Intimation Of Board Meeting Scheduled To Be Held On August 21, 2024
Procter & Gamble Health Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/08/2024 ,inter alia, to consider and approve In terms of Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015, we would like to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Wednesday, August 21, 2024, inter alia, to consider and approve Audited Financial Results and Statements for the Financial Year ended June 30, 2024 and to consider recommendation of dividend (if any). Procter & Gamble Health Ltd - 500126 - Closure of Trading Window
Dear Sir, Please be informed that we have issued share certificate to our shareholder, as detailed in enclosed letter. Request you to kindly take note of the same. Procter & Gamble Health Ltd - 500126 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
There has been a typographical error in the share certificate details mentioned in the earlier announcement of even date, in this regard find enclosed revised details with respect to loss of share certificates of shareholders of the Company as intimated by the RTA, Kfin technologies Limited. Procter & Gamble Health Ltd - 500126 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Find enclosed details with respect to loss of share certificate(s) of shareholder(s) of the Company as intimated by the RTA, Kfin Technologies Ltd. Procter & Gamble Health Ltd - 500126 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Dear Sir, Please be informed that we have issued duplicate share certificate to our shareholder as per attached letter. Kindly take the same on record. Q3FY24 Quarterly Result Announced for Procter & Gamble Health Ltd.
Pharmaceuticals company Procter & Gamble Health announced Q3FY24 results: Financial Highlights: Procter & Gamble Health Limited reported a decrease in sales and profit after tax for the Q3FY24. The total sales for the quarter were Rs 248 crore compared to Rs 316 crore a year ago, marking a downturn. Correspondingly, the Profit After Tax (PAT) also declined by 21% to Rs 46 crore. For the nine-month period ending March 31, 2024, P&G; Health's sales were recorded at Rs 852 crore, which exhibited a slight reduction from the previous year's sales of Rs 913 crore. The PAT for the nine-month period stood at 184 crore, experiencing a decrease from the Rs 200 crore reported in the prior year. Milind Thatte, Managing Director, P&G; Health India, said, “The Company’s continued efforts to strengthen our reach and distribution with a transformed go-to-market model reflected in a one-time impact on the quarter’s sales owing to the transition and optimization of trade management and inventory. However, we have seen sales recover in the months of March and April. We continue to drive operational efficiency and explore innovative solutions to accelerate category growth and demand for our portfolio of trusted, quality healthcare brands. The quarter also witnessed prescription growth and share gain for our doctor detailed products indicating a robust demand, and increased efforts to improve awareness of our self-select products. We remain confident in our integrated growth strategy of a focused product portfolio where performance drives brand choice, superiority, productivity, constructive disruption, and an agile and accountable organization structure to help drive growth and value creation,”he added. Result PDF Procter & Gamble Health Ltd - 500126 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Find enclosed press release on the unaudited financial results for the quarter ended March 31,2024 Procter & Gamble Health Ltd - 500126 - Quarter Ended March 31,2024
Enclosed herewith are the unaudited financial results for the quarter ended March 31,2024 and the limited review report of the auditors thereon. Procter & Gamble Health Ltd - 500126 - Board Meeting Outcome for Unaudited Financial Results For The Quarter Ended March 31,2024
Enclosed herewith are the unaudited financial results for the quarter ended March 31,2024 along with the limited review report of the auditors thereon.